However, in sharp contrast with the aforementioned evidence, a recent study investigating glutamate metabolism in astrocytes expressing FTD-associated CHMP2B variants unexpectedly uncovered enhanced uptake and metabolism of the neurotransmitter [157]. This evidence concerns the gene CHMP2B and frontotemporal dementia.